See also this year's filing and all EDGAR filings for this company.
PDF Report 0001274792_2013_Merrimack_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001274792, Merrimack Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 128,301,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 5,770,000 |
| 2 | PropertyPlantAndEquipmentNet | 6,297,000 |
| 3 | remainder_Assets | 8,606,000 |
| 4 | LiabilitiesCurrent | 38,520,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 116,874,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,805,000 |
| 9 | ResearchAndDevelopmentExpense | 125,858,000 |
| 10 | remainder_Expenses | 553,000 |
| 11 | remainder_Revenues | 48,921,000 |
| 12 | remainder_NetIncome | 1,541,000 |
| 13 | remainder_ComprehensiveNetIncome | 439,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 148,974,000 |
| 1 | Liabilities | 155,394,000 |
| 2 | Expenses | 142,216,000 |
| 3 | Revenues | 48,921,000 |
| 4 | StockholdersEquity | -6,420,000 |
| 5 | NetIncome | -91,754,000 |
| 6 | ComprehensiveNetIncome | -91,534,500 |
| 7 | BaseVar | 248,742,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.693 |
| 9 | EconomicCapitalRatio | 1.36 |
Edgar->Model Mapping
Feature Distribution
